0001701259-18-000002.txt : 20180605 0001701259-18-000002.hdr.sgml : 20180605 20180604182628 ACCESSION NUMBER: 0001701259-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180604 EFFECTIVENESS DATE: 20180605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Phage Therapeutics, Inc. CENTRAL INDEX KEY: 0001701259 IRS NUMBER: 814208730 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313841 FILM NUMBER: 18879525 BUSINESS ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2408992532 MAIL ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001701259 Adaptive Phage Therapeutics, Inc. 22 FIRSTFIELD ROAD SUITE 125 GAITHERSBURG MD MARYLAND 20878 240-899-2532 DELAWARE None None Corporation true 2017 Gregory Louis Merril 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Executive Officer Director Carl Merril 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Executive Officer Director William Mutryn 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Director Pharmaceuticals Decline to Disclose 06b false 2018-01-24 false true false 0 5000000 2350000 2650000 false 8 0 0 0 false Adaptive Phage Therapeutics, Inc. /s/ Gregory Louis Merril Gregory Louis Merril CEO 2018-06-04